Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Faculdade De Ciências Da Universidade De Lisboa is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. KOSTURKO, GEORGE W is the busiest examiner, currently handling 1 pending action.
The presence of 2 distinct art units indicates that the university's pharmaceutical innovations are being evaluated by different technical teams. This distribution requires the university to navigate 2 separate sets of examiner expectations and art unit policies. Practitioners must ensure that arguments remain consistent across these 2 different examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSTURKO, GEORGE W | 1 | 54.6% | +49.0% |
| MOORE, SUSANNA | 1 | 68.0% | +31.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837191 | USE OF AN ORGANOMETALLIC RUTHENIUM COMPOUND FOR THE PREVENTION AND/OR TREATMENT OF DISEASES AND/OR CONDITIONS RELATED TO CANCER IN AN INDIVIDUAL | KOSTURKO, GEORGE W | — |
| 18717702 | CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES | MOORE, SUSANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837191 | USE OF AN ORGANOMETALLIC RUTHENIUM COMPOUND FOR THE PREVENTION AND/OR TREATMENT OF DISEASES AND/OR CONDITIONS RELATED TO CANCER IN AN INDIVIDUAL | KOSTURKO, GEORGE W | — |
| 18717702 | CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES | MOORE, SUSANNA | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18837191 | USE OF AN ORGANOMETALLIC RUTHENIUM COMPOUND FOR THE PREVENTION AND/OR TREATMENT OF DISEASES AND/OR CONDITIONS RELATED TO CANCER IN AN INDIVIDUAL | KOSTURKO, GEORGE W | 1621 | §102§103§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18717702 | CATIONIC STEROID COMPOUNDS, METHOD OF OBTAINING THEREOF, FORMULATIONS COMPRISING THEREOF AND THEIR USES | MOORE, SUSANNA | 1624 | §102§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFaculdade De Ciências Da Universidade De Lisboa has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
George W Kosturko has the most, with 1 of Faculdade De Ciências Da Universidade De Lisboa's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
